Akebia Therapeutics Vs. Bel Fuse Industry Stock Comparison

Sell

36

AKBA
Akebia Therapeutics

Last Price:

1.37

Seasonality Move:

-5.8%

Buy

76

BELFB
Bel Fuse

Last Price:

80.89

Seasonality Move:

13.94%

Sell

36

Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

The current Akebia Therapeutics [AKBA] share price is $1.36. The Score for AKBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

76

Bel Fuse (BELFB) is a Buy

Is Bel Fuse a Buy, Sell or Hold?

The current Bel Fuse [BELFB] share price is $81.03. The Score for BELFB is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
BELFB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

The Akebia Therapeutics share price today is $1.36
The current trend is moderately bearish and AKBA is experiencing slight selling pressure.

BELFB Stock Price Chart

What is Bel Fuse's stock price today?

The Bel Fuse share price today is $81.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BELFB is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKBA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0	Buy
Relative Strength Index (14 RSI):	45.8	Sell
Chaikin Money Flow:	-155051	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.39 - 1.51)	Sell
Bollinger Bands (100):	(1.07 - 1.43)	Buy

BELFB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.86	Buy
Relative Strength Index (14 RSI):	77.85	Buy
Chaikin Money Flow:	207452	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(63.15 - 69.97)	Buy
Bollinger Bands (100):	(62.12 - 69.5)	Buy

AKBA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.41	Sell
20-day SMA:	1.45	Sell
50-day SMA:	1.39	Sell
200-day SMA:	1.37	Sell
8-day EMA:	1.4	Sell
20-day EMA:	1.41	Sell
50-day EMA:	1.36	Sell
200-day EMA:	1.3	Buy

BELFB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	69.56	Buy
20-day SMA:	66.99	Buy
50-day SMA:	67.04	Buy
200-day SMA:	63.64	Buy
8-day EMA:	70.81	Buy
20-day EMA:	68.04	Buy
50-day EMA:	66.68	Buy
200-day EMA:	62.24	Buy

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

Bel Fuse Earnings Growth & BELFB Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.66 per share, a decrease this year of $1.89 per share, and an increase next year of $0.28 per share.

Akebia Therapeutics Technical Analysis

	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19
	Sep
	06	09	10	11	12	13	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bel Fuse Technical Analysis

	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19
	Sep
	06	09	10	11	12	13	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):